NS Pharma Inc.

NS Pharma Inc. We are a highly focused, research-driven biopharmaceutical company working in rare diseases. If this is a medical emergency, please dial 911. NS Pharma, Inc.

While we try to respond to questions in a timely manner, please note that the Facebook page for NS Pharma is not monitored 24/7, and questions or concerns posted on the channels publicly or via private/direct messages to page admins may not be seen or replied to in real time. If you are contacting us about a medical condition or concern, please know that we are unable to make any diagnosis or offer medical advice, so please call your physician to ensure a timely response to your medical needs. reserves the right to contact posters for further information or to remove posts that do not comply with these community guidelines. We reserve the right to ban individuals who continue to engage in conduct that goes against our policies. We encourage visitors of this page to respect fellow community members and the posting guidelines, and to understand that NS Pharma, Inc. reserves the right to remove postings that are:
(a) abusive, defamatory, or obscene;
(b) fraudulent, deceptive or misleading;
(c) in violation of any intellectual property right of another;
(d) in violation of any law or regulation;
(e) offensive, graphically or in tone;
(f) promoting improper use or off label use of any medication or Rx medical therapy;
(g) promoting other pages or web sites;
(h) utilizing profanity or suggesting it via emojis;
(i) encouraging friending of yourself or others (e.g., "add me");
(j) discussing or promoting competitors or other products;
(h) attempting to offer medical advice, even if you are a practicing healthcare provider;
(i) comments that are off topic or considered spam. NS Pharma, Inc, is not responsible for the accuracy of the opinions, information and advice of comments on this page not specifically posted by us. Thank you for adhering to our guidelines.

The dystrophin gene is made up of 79 segments known as exons. Exon-skipping therapies are designed to skip over a specif...
03/30/2026

The dystrophin gene is made up of 79 segments known as exons. Exon-skipping therapies are designed to skip over a specific exon, which may help the body work around certain genetic mutations.

Genetic testing can help determine which exons are impacted and whether exon-skipping could be a potential approach.

Speak with your healthcare provider about testing options and learn more about DMD here: https://ow.ly/emjI50YB61H

We’re looking forward to spending time at this upcoming community event and stepping into meaningful conversations aroun...
03/27/2026

We’re looking forward to spending time at this upcoming community event and stepping into meaningful conversations around rare disease care. 💙

Opportunities like this remind us that progress is not only measured in data, but also in dialogue. Listening to lived experiences, sharing perspectives, and continuing to learn together all play a role in moving care forward.

If you will be attending, we're looking forward to connecting and continuing the conversation.

Learn more about the event: https://ow.ly/KaGF50YzCzX

03/25/2026

When your immune system shifts from defense to offense, your body might feel like it’s under attack.

Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare disease, characterized by a mix of symptoms including asthma, sinusitis, skin rashes, and nerve pain - which makes it challenging to diagnose due to its rarity and symptom overlap with other diseases.

EGPA patients often have higher than normal levels of an immune cell called eosinophils, and the overactivity of these cells causes inflammation of small blood vessels. Immune activity is regulated by signaling pathways that involve enzymes like JAK1. JAK1 inhibitors are designed to turn down the activity of immune cells, and are being studied as an approach to address inflammation associated with EGPA.

Learn how our NS-229 JAK1 inhibitor is being evaluated in a Phase 2 global clinical trial:
https://ow.ly/mngi50YyAPe

03/24/2026

Duchenne muscular dystrophy is part of your story, not the whole story.

Brantley was just 4 years old when his family began noticing early signs of Duchenne. Doctors later discovered he had low levels of dystrophin - the vital protein that helps strengthen and protect muscles. Without functional dystrophin, his family worried whether he could continue the activities he loves, like woodworking.

Exon-skipping therapies help the body produce a shortened but usable form of dystrophin that slows the progression of muscle degeneration, so that patients like Bradley continue to pursue their passions and dreams.

Learn more about NS Pharma’s work on DMD treatments: https://ow.ly/xenj50Yy30q

03/23/2026

Duchenne muscular dystrophy is part of your story, not the whole story.

Bradley was just 4 years old when his family began noticing early signs of Duchenne. Doctors later discovered he had low levels of dystrophin - the vital protein that helps strengthen and protect muscles. Without functional dystrophin, his family worried whether he could continue the activities he loves, like woodworking.

Exon-skipping therapies help the body produce a shortened but usable form of dystrophin that slows the progression of muscle degeneration, so that patients like Bradley continue to pursue their passions and dreams.

Learn more about NS Pharma’s work on DMD treatments: https://ow.ly/FMJm50YxtMZ

We are proud to support and attend the 2026 Brian McKenna TetraSki Express National Championship on March 27 at Powder M...
03/20/2026

We are proud to support and attend the 2026 Brian McKenna TetraSki Express National Championship on March 27 at Powder Mountain Resort in Eden, Utah.

This extraordinary event highlights the power of adaptive technology, athleticism, and resilience as athletes with complex physical injury or illness compete in TetraSki and Snow’Kart downhill racing

What a celebration of inclusion, innovation, and the human spirit! We're honored to stand alongside a community that continues to redefine what is possible and to support initiatives that promote equity and opportunity in adaptive sports.

Learn more about the event: https://ow.ly/Qp6p50YwMcT

We’re glad to be part of this upcoming event and to continue showing up for the rare disease community. 💙Moments like th...
03/18/2026

We’re glad to be part of this upcoming event and to continue showing up for the rare disease community. 💙

Moments like these are an opportunity to pause, reflect on progress, and stay grounded in what matters most. Every conversation and every connection helps shape how we think about care, access, and the future of treatment.

We look forward to seeing you there!

Learn more about the event: https://ow.ly/maS550YvHtO

Thank you to Project Alive and the Hunter syndrome community for a meaningful Building a Future Together Conference. 💙Sp...
03/16/2026

Thank you to Project Alive and the Hunter syndrome community for a meaningful Building a Future Together Conference. 💙

Spending time with families, advocates, and community leaders in Costa Mesa was a powerful reminder of the strength and dedication that drives progress in rare disease care. The conversations, insights, and shared experiences continue to shape how we listen, learn, and move research forward.

We are grateful to everyone who welcomed us into these discussions and look forward to continuing our work alongside this incredible community.

We’re looking forward to attending the Akari Foundation Workshop on March 14 to 15, 2026. 💙Workshops like this create me...
03/12/2026

We’re looking forward to attending the Akari Foundation Workshop on March 14 to 15, 2026. 💙

Workshops like this create meaningful space for focused discussion, shared learning, and continued momentum in rare disease research and care. Spending time in these environments allows us to stay connected to the evolving needs of the community and the science shaping the future.

We appreciate the Akari Foundation’s dedication to bringing people together around a shared purpose and look forward to seeing you there!

Learn more about the workshop: https://ow.ly/AzGa50YsKmi

We're excited to be attending the Project Alive Building a Future Together Conference on March 14th-15th, 2026. 💙This ga...
03/11/2026

We're excited to be attending the Project Alive Building a Future Together Conference on March 14th-15th, 2026. 💙

This gathering is an important opportunity to listen, learn, and engage with families and advocates in the Hunter syndrome community. Time spent together in conversation helps strengthen understanding and reinforces the shared commitment to improving care and advancing research.

We're grateful for the dedication of Project Alive and the families who continue to lead with courage and collaboration. We look forward to being part of the experience.

Learn more about the conference: https://ow.ly/5GMK50YsfZC

Our team is onsite at MDA 2026 and looking forward to engaging with our community! On Sunday and Monday, we’ll be presen...
03/09/2026

Our team is onsite at MDA 2026 and looking forward to engaging with our community! On Sunday and Monday, we’ll be presenting three additional posters highlighting real world evidence. Stop by posters 146 M, 168 M & 57 S to learn more!

Address

140 E Ridgewood Avenue
Paramus, NJ
07652

Alerts

Be the first to know and let us send you an email when NS Pharma Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to NS Pharma Inc.:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram